Magnetic resonance imaging outcomes, neurofilament light, smoking, and treatment with erythropoietin, methylprednisolone, natalizumab or placebo in progressive multiple sclerosis

F. Sellebjerg,R. Ratzer,J. Romme Christensen, K. Schreiber,M. Magyari, C. Ammitzboll,H. Lundell, H. R. Siebner, P. S. Sorensen

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要